Key result
Higher serum advanced glycation end products (AGEs) concentration was independently associated with frequent premature ventricular contractions in patients with ST-segment elevation myocardial infarction (adjusted OR 1.86).
Why the study?
The study aimed to investigate the mechanisms by which advanced glycation end products (AGEs) exacerbate post-myocardial infarction ventricular arrhythmias.
Does anti-RAGE antibody treatment reduce AGEs-exacerbated post-MI ventricular arrhythmias?
Cohort (n=101)
No
Does anti-RAGE antibody treatment reduce AGEs-exacerbated post-MI ventricular arrhythmias?
Odds Ratio: 1.86 (95% CI 1.09–3.18)
p-value: p=0.022
Advanced glycation end products (AGEs) exacerbate post-MI ventricular arrhythmias via the ER stress-mediated PERK/CaN/RyR2 signaling pathway, which can be attenuated by RAGE blockade.
Background: The current study was aimed to investigate the mechanisms of advanced glycation end products (AGEs) in exacerbating post- myocardial infarction (MI) ventricular arrhythmias (VAs). Methods: Correlation between premature ventricular contractions (PVCs) and serum AGEs concentrations was analyzed in a cohort consisted of 101 STEMI patients with culprit vessel of left anterior descending artery (LAD). Established MI rat model were treated with AGEs and/or anti- receptor for AGE (RAGE) antibody. Electrocardiography was used to record VAs. Myocytes were isolated from adjacent area around infracted region. Immunofluorescent stains were used to evaluate association between FKBP12.6 (FK506-bindingprotein 12.6) and ryanodine receptor 2 (RyR2). Calcium sparks were evaluated by confocal microscope. Protein expression and phosphorylation were assessed by Western blotting. A colorimetric method was used to determine the enzymatic activity of calcineurin (CaN). [ 3 H]-ryanodine binding assay was carried out to detect the RyR2 channel activity. Results: In the cohort study, significantly increased amount of (PVCs) were found in STEMI patients with diabetes (P<0.05). Serum AGEs concentration was significantly positively correlated with PVCs amount in STEMI patients (r=0.416, P<0.001). Multivariate analysis showed serum AGEs concentration was independently and positively related to frequent PVCs (adjusted hazard ratio, 1.86; 95% CI, 1.09-3.18, P=0.022). In the animal study, increased glucose regulated protein 78 (GRP78) expression, protein kinase RNA-like ER kinase (PERK) phosphorylation, CaN enzymatic activity, FKBP12.6-RyR2 disassociation, RyR2 channel opening and endoplasmic reticulum (ER) calcium releasing were found in MI animals exposed to AGEs, which were attenuated by anti-RAGE antibody treatment. This RAGE blocking also significantly lowered the VAs amount in MI animals exposed to AGEs. Conclusions: Hyper-activation of ER stress- mediated PERK/CaN/RyR2 signaling participated in AGEs- exacerbated post-MI VAs.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2020) conducted a cohort in ST-segment elevation myocardial infarction (STEMI) (n=101). Serum advanced glycation end products (AGEs) vs. Lower serum AGEs concentration was evaluated on Frequent premature ventricular contractions (PVCs) (OR 1.86, 95% CI 1.09-3.18, p=0.022). Higher serum advanced glycation end products (AGEs) concentration was independently associated with frequent premature ventricular contractions in patients with ST-segment elevation myocardial infarction (adjusted OR 1.86).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: